11
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Therapeutic Effect of Ok-432 Induced Endogenous Tnf on Tumor Bearing Mice and Cancer Patients

, , , , , , , & show all
Pages 53-65 | Published online: 28 Sep 2008

References

  • Watanabe N., Niitsu Y., Sone H., Neda H., Urushizaki I., Yamamoto A., Nagamuta M., Sugawara Y. Therapeutic effect of endogenous tumor necrosis factor on ascites Meth A sarcoma. J. Immunopharmacology 1986; 8: 271–283
  • Tamura K., Ishida N. Induction of tumor necrosis factor (TNF) in tumor-bearing mice. Jpn. J. Cancer Chemother. 1984; 11: 1369–1378
  • Yamamoto A., Nagamuta M., Usami H., Sugawara Y., Watanabe N., Niitsu Y., Urushizaki I. Release of tumor necrosis factor (TNF) into mouse peritoneal fluids by OK-432, a streptococcal preparation. Immunopharmacology 1986; 11: 79–86
  • Nagamuta M., Yamamoto A., Usami H., Sugawara Y., Watanabe N., Niitsu Y., Urushizaki I. Characterization of a cytotoxic factor induced in mouse peritoneal fluid by OK-432. Immuno. letters 1986; 13: 101–105
  • Yamazaki S., Onishi E., Enami K., Natori K., Kohase M., Sakamoto H., Tanouchi M., Hayashi H. Proposal of standardized methods and reference for assaying recombinant human tumor necrosis factor. Jpn. J. Med. Sci. Biol. 1986; 39: 105–118
  • Shirai T., Yamaguchi H., Todd C. W., Wallace R. B. Cloning and expression in Escherichia coli of the gene for human tumor necrosis factor. Nature 1985; 313: 803–806
  • Penica D., Nedwin G. E., Hayflick J. S., Seeburg P. H., Derynck R., Palladino M. A., Kohr W. J., Aggarwal B. B., Coeddel D. U. Human tumor necrosis factor: Precursor structure, expression and homology to lymphotoxin. Nature 1984; 312: 724–729
  • Wang A. M., Creasey A. A., Lander M. B., Lin L. S., Strickler J., Van Arsdell J. N., Yamamoto R., Mark D. F. Molecular cloning of the complementary DNA for human tumor necrosis factor. Science 1985; 228: 149–154
  • Ota K., Oyama A., Kurita S., Nishimura M., Ogawa M., Kamei Y., Doi M., Murakami M., Sugiura T., Goto T. Effect of hemolytic streptococcal preparation OK-432 for pleuritis and peritonitis carcinomatosa. Jpn. J. Cancer Chemother. 1975; 2: 255–265
  • Uchida A., Micksche M. Intrapleural administration of OK-432 in cancer patients: Activation of NK cells and reduction of supressor cells. Int. J. Cancer 1983; 31: 1–5
  • Saito M., Ebina T., Koi M., Yamaguchi T., Kawade Y., Ishida N. Induction of interferon-γ in mice spleen cells by OK-432, a preparation of Streptococcus pyogenes. Cell. Immunol. 1982; 68: 184–192

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.